Glooko’s new version includes support for the Ambulatory Glucose Profile (AGP), as well as new dashboards and reports.
Diabetes data management company Glooko announced the release of its updated Glooko Web Application (Population Tracker). The web analytics platform update includes streamlined navigation and a new collection of diabetes analytics, charts, and graphs.
The company spent more than a year researching, developing, and identifying the most insightful analytics features included in both the Diasend and Glooko platforms. Both platforms are intended for use by people with diabetes and the medical personnel who treat the disease.
The new web app version available in the United States and Canada and launching shortly in Europe, includes support for IDC’s Ambulatory Glucose Profile (AGP). Its key features include:
- Reports that give insight about the influence of exercise, carbs, medication, and other factors on glucose levels
- Simplified, color-coded charts and graphs that streamline data for easier interpretation
- Enhanced statistics, bolus tracking features, and insulin pump reports
- An updated PDF wizard that simplifies report viewing and sharing
“We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today,” said Sam Wyndbrant, Director of Product Management at Glooko. “We listened to our customers’ feedback and added new features that will allow users to further separate the data that really matters from background noise. Patients and clinicians can now efficiently gain actionable insights from their data better than ever before.”
More than 7,000 clinics in 23 countries use Glooko’s platform, which extracts data from fitness/ activity trackers and diabetes devices to provide information about:
- Blood sugar levels
- Blood pressure
- Insulin levels
Learn more by visiting www.glooko.com